Mail-Order Drug Spend Up 13.6% In 2004; Overall Rx Growth Slows
Executive Summary
Spending on mail-order drugs grew at a rate of 13.6% in 2004, compared to 2% growth at retail outlets, CMS researchers report
You may also be interested in...
Follow-On Biologics Pathway Unlikely Without Confirmed FDA Commissioner
FDA is unlikely to proceed with developing a follow-on biologics pathway until a permanent commissioner is confirmed, a Senate Health Committee staffer said at a Food & Drug Law Institute conference in Washington, D.C., Nov. 16
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials